Prevalence and correlates of somatoform disorders in the elderly: Results of a European study.
Standard
Prevalence and correlates of somatoform disorders in the elderly: Results of a European study. / Dehoust, Maria Christina; Schulz, Holger; Härter, Martin; Volkert, Jana; Sehner, Susanne; Drabik, Anna; Wegscheider, Karl; Canuto, Alessandra; Weber, Kerstin; Crawford, Mike; Quirk, Alan; Grassi, Luigi; DaRonch, Chiara; Munoz, Manuel; Ausin, Berta; Santos-Olmo, Anna; Shalev, Arieh; Rotenstein, Ora; Hershkowitz, Yael; Strehle, Jens; Wittchen, Hans-Ulrich; Andreas, Sylke.
In: INT J METH PSYCH RES, Vol. 26, No. 1, 03.2017, p. Art. e1550 .Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Prevalence and correlates of somatoform disorders in the elderly: Results of a European study.
AU - Dehoust, Maria Christina
AU - Schulz, Holger
AU - Härter, Martin
AU - Volkert, Jana
AU - Sehner, Susanne
AU - Drabik, Anna
AU - Wegscheider, Karl
AU - Canuto, Alessandra
AU - Weber, Kerstin
AU - Crawford, Mike
AU - Quirk, Alan
AU - Grassi, Luigi
AU - DaRonch, Chiara
AU - Munoz, Manuel
AU - Ausin, Berta
AU - Santos-Olmo, Anna
AU - Shalev, Arieh
AU - Rotenstein, Ora
AU - Hershkowitz, Yael
AU - Strehle, Jens
AU - Wittchen, Hans-Ulrich
AU - Andreas, Sylke
N1 - Copyright © 2017 John Wiley & Sons, Ltd.
PY - 2017/3
Y1 - 2017/3
N2 - Somatoform disorders have rarely been addressed in epidemiological and health care services studies of the elderly. The few existing studies vary considerably in their methodologies limiting comparability of findings. Data come from the MentDis_ICF65+ study, in which a total of 3142 community-dwelling respondents aged 65-84 years from six different countries were assessed by the Composite International Diagnostic Interview adapted to the needs of the elderly (CIDI65+). The 12-month prevalence rate for any somatoform disorders was found to be 3.8, whereby the prevalence for somatization disorder according to DSM-IV was 0%, the prevalence for abridged somatization was 1.7% and the rate for 12-months somatoform pain disorder was 2.6%. We found a significant variation by study centre (p < 0.005). There was a significant gender difference for pain disorder, but not for abridged somatization. Significant age-related effects revealed for both disorder groups. Somatoform disorders were found to be associated with other mental disorders [odds ratio (OR) anxiety =4.8, OR affective disorders 3.6], as well as with several impairments and disabilities. Somatoform disorders are prevalent, highly impairing conditions in older adults, which are often associated with other mental disorders and should receive more research and clinical attention.
AB - Somatoform disorders have rarely been addressed in epidemiological and health care services studies of the elderly. The few existing studies vary considerably in their methodologies limiting comparability of findings. Data come from the MentDis_ICF65+ study, in which a total of 3142 community-dwelling respondents aged 65-84 years from six different countries were assessed by the Composite International Diagnostic Interview adapted to the needs of the elderly (CIDI65+). The 12-month prevalence rate for any somatoform disorders was found to be 3.8, whereby the prevalence for somatization disorder according to DSM-IV was 0%, the prevalence for abridged somatization was 1.7% and the rate for 12-months somatoform pain disorder was 2.6%. We found a significant variation by study centre (p < 0.005). There was a significant gender difference for pain disorder, but not for abridged somatization. Significant age-related effects revealed for both disorder groups. Somatoform disorders were found to be associated with other mental disorders [odds ratio (OR) anxiety =4.8, OR affective disorders 3.6], as well as with several impairments and disabilities. Somatoform disorders are prevalent, highly impairing conditions in older adults, which are often associated with other mental disorders and should receive more research and clinical attention.
KW - Journal Article
U2 - 10.1002/mpr.1550
DO - 10.1002/mpr.1550
M3 - SCORING: Journal article
C2 - 28150357
VL - 26
SP - Art. e1550
JO - INT J METH PSYCH RES
JF - INT J METH PSYCH RES
SN - 1049-8931
IS - 1
ER -